Company OverviewCelbion is a South Korean biotechnology company specializing in the development and commercialization of innovative therapies for various diseases. The company focuses on developing antibody-drug conjugates (ADCs) and other targeted therapies, with a particular emphasis on cancer treatments. Celbion's pipeline consists of several promising candidates, including its lead asset, CB..
